Dashboard
Manage Tickers

XFOR X4 Pharmaceuticals, Inc

Nasdaq x4pharma.com


$ 3.72 $ -0.14 (-3.62 %)    

Thursday, 13-Nov-2025 15:59:55 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 609.25 $ -9.26 (-1.5 %)
DIA $ 475.42 $ -6.59 (-1.37 %)
SPY $ 673.08 $ -8.41 (-1.24 %)
TLT $ 89.38 $ -0.42 (-0.46 %)
GLD $ 385.00 $ -4.31 (-1.11 %)
$ 3.73
$ 3.81
$ 3.69 x 2
$ 3.83 x 1,344
$ 3.66 - $ 3.85
$ 1.35 - $ 26.83
276,278
na
326.14M
$ 1.43
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-08-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 03-25-2025 12-31-2024 10-K
5 11-13-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-07-2024 03-31-2024 10-Q
8 03-21-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-10-2023 06-30-2023 10-Q
11 05-04-2023 03-31-2023 10-Q
12 03-21-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-12-2022 03-31-2022 10-Q
16 03-17-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-03-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 03-19-2021 12-31-2020 10-K
21 11-05-2020 09-30-2020 10-Q
22 08-04-2020 06-30-2020 10-Q
23 05-07-2020 03-31-2020 10-Q
24 03-12-2020 12-31-2019 10-K
25 11-07-2019 09-30-2019 10-Q
26 08-07-2019 06-30-2019 10-Q
27 05-15-2019 03-31-2019 10-Q
28 03-11-2019 12-31-2018 10-K
29 11-09-2018 09-30-2018 10-Q
30 08-13-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 03-09-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-maintains-buy-on-x4-pharmaceuticals-raises-price-target-to-5
HC Wainwright & Co. Maintains Buy on X4 Ph...
11/10/2025 12:09:44

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains X4 Pharmaceuticals (NASDAQ:XFOR) with a Buy and raises the ...

x4-pharmaceuticals-q3-eps-069-beats-082-estimate-sales-1765m-miss-1901m-estimate
X4 Pharmaceuticals Q3 EPS $(0.69) Beats $(...
11/05/2025 13:22:06

X4 Pharmaceuticals (NASDAQ:XFOR) reported quarterly losses of $(0.69) per share which beat the analyst consensus estimate of $(...

x4-pharmaceuticals-prices-135m-public-offering-of-4586m-common-shares-at-290-each-to-advance-phase-3-rare-disease-program
X4 Pharmaceuticals Prices $135M Public Off...
10/24/2025 06:25:31

And, in lieu of common stock to certain investors, pre-funded warrants to purchase up to 700,000 shares of its common stock at ...

x4-pharmaceuticals-launches-of-an-underwritten-public-offering-of-its-common-stock-no-financial-terms-disclosed
X4 Pharmaceuticals Launches Of An Underwri...
10/23/2025 20:05:38

X4 Pharmaceuticals (NASDAQ:XFOR) ("X4" or the "Company"), a company driven to improve the lives of people with ...

x4-pharmaceuticals-announces-strategic-restructuring-with-50-workforce-reduction-expected-to-deliver-13m-annualized-cost-savings
X4 Pharmaceuticals Announces Strategic Res...
09/17/2025 11:12:37

Organizational restructuring including a 50% reduction in workforce that is anticipated to result in annualized cost savings of...

stifel-maintains-buy-on-x4-pharmaceuticals-lowers-price-target-to-9
Stifel Maintains Buy on X4 Pharmaceuticals...
08/29/2025 13:13:31

Stifel analyst Stephen Willey maintains X4 Pharmaceuticals (NASDAQ:XFOR) with a Buy and lowers the price target from $30 to $9.

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/19/2025 17:06:05

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
08/18/2025 21:06:13

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/13/2025 12:08:29

hc-wainwright--co-maintains-buy-on-x4-pharmaceuticals-lowers-price-target-to-35
HC Wainwright & Co. Maintains Buy on X4 Ph...
08/13/2025 11:55:47

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains X4 Pharmaceuticals (NASDAQ:XFOR) with a Buy and lowers the ...

trading-halt-halt-status-updated-at-72500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 7:25:...
08/13/2025 11:25:04

trading-halt-halted-at-33744-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 3:37:44 p.m. ET - ...
08/12/2025 19:37:49

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/12/2025 17:07:02

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
08/12/2025 12:08:34

x4-pharmaceuticals-secures-60m-private-placement-in-public-equity-financing-with-significant-management-and-board-changes
X4 Pharmaceuticals Secures $60M Private Pl...
08/12/2025 11:21:23

x4-pharmaceuticals-president-and-ceo-paula-ragan-and-cfo-adam-mostafa-have-stepped-down-from-their-respective-roles-x4-board-of-directors-has-appointed-adam-craig-as-executive-chair-john-volpone-as-president-and-david-kirske-as-cfo-effectively-immediately
X4 Pharmaceuticals' President And CEO Paul...
08/12/2025 11:16:47

x4-pharmaceuticals-announced-private-placement-in-public-equity-financing-of-approximately-60m
X4 Pharmaceuticals Announced Private Place...
08/12/2025 11:14:15

$60 million PIPE financing led by Coastlands Capital, Bain Capital Life Sciences and New Enterprise AssociatesNewly appointed b...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
07/28/2025 17:06:06

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/24/2025 21:06:08

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/24/2025 17:06:06

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION